China's biopharma industry sales up 31 pct from Jan. to Nov. 2010
Shanghai. January 7. INTERFAX-CHINA - China's biopharmaceutical industry generated sales revenue of RMB 106.25 billion ($16.03 billion) during the first 11 months of 2010, up 30.55 percent year-on-year, according to National Bureau of Statistics (NBS) figures published by pharmaceutical information provider Healthoo.com on Jan. 6.
The statistics indicate that sales by large biopharmaceutical manufacturers over the period surged 33.04 percent year-on-year, while sales by small- and medium-sized manufacturers saw growth of 33.04 percent and 21.82 percent, respectively.
According to the report, nearly 90 percent of China's biopharmaceutical manufacturers are small-sized.
The report attributed the rapid sales growth to increased government support for disease prevention and treatment.
The figures show that small-sized biopharmaceutical manufacturers saw their profits increase by 6.45 percent during the first eleven months. Middle- and large-sized manufacturers saw profit growth of 8.58 and 9.65 percent over the period, respectively.
By region, the top four performers from January to November 2010 were Shandong, Jiangsu, Henan and Guangdong, which saw aggregate sales of RMB 54.42 billion ($8.21 billion), or 51.22 percent of the national total.